These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1750072)
1. The renal artery resistive index and serum creatinine changes during the treatment of renal allograft rejection with the monoclonal antibody OKT3. Pescovitz MD; Leapman SB; Milgrom ML; Kopecky KK; Filo RS Transplantation; 1991 Dec; 52(6):1090-2. PubMed ID: 1750072 [No Abstract] [Full Text] [Related]
3. Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection. Lucas BA; Waid TH; Thompson JS; Brown SA; Munch LC; McKeown JW; Kryscio RJ; Prebeck RJ Transplant Proc; 1993 Feb; 25(1 Pt 1):543-5. PubMed ID: 8438406 [No Abstract] [Full Text] [Related]
4. The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis. Haberal M; Sert S; Gülay H; Arslan G; Bilgin N Transplant Proc; 1990 Aug; 22(4):1761-3. PubMed ID: 2117801 [No Abstract] [Full Text] [Related]
5. Rescue of severe steroid-resistant rejection with OKT3.PAN. Ponticelli C; Rivolta E; Tarantino A; De Vecchi A; Vegeto A Transplant Proc; 1987 Feb; 19(1 Pt 3):1908-9. PubMed ID: 3274449 [No Abstract] [Full Text] [Related]
6. Uses of orthoclone OKT3 for prophylaxis of rejection and induction in initial nonfunction in kidney transplantation. Kahana L; Ackermann J; Lefor W; Weinstein S; Wright C; DeQuesada A; Alveranga D; Baxter J; Shires D Transplant Proc; 1990 Aug; 22(4):1755-8. PubMed ID: 2117799 [TBL] [Abstract][Full Text] [Related]
7. [Neurologic complications induced by the treatment of the acute renal allograft rejection with the monoclonal antibody OKT3]. Fernández O; Romero F; Bravo M; Burgos D; Cabello M; González-Molina M Neurologia; 1993 Oct; 8(8):277-80. PubMed ID: 8240843 [TBL] [Abstract][Full Text] [Related]
8. Treatment with OKT3 and cyclosporine for acute allograft rejection. Schulak JA; Mayes JT; Hricik DE Transplant Proc; 1991 Aug; 23(4):2119-22. PubMed ID: 1908150 [TBL] [Abstract][Full Text] [Related]
9. Utility of pulsed Doppler in the diagnosis and follow-up of acute vascular graft rejection treated with OKT3 monoclonal antibody or antilymphocyte serum. Gilabert R; Campistol JM; Bru C; Vilardell J; Bianchi L; Andreu J Transplantation; 1991 Mar; 51(3):614-8. PubMed ID: 1900963 [TBL] [Abstract][Full Text] [Related]
10. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens. Monaco A; Goldstein G; Barnes L Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137 [No Abstract] [Full Text] [Related]
11. Anti-LFA-1 adhesion molecule monoclonal antibody in prophylaxis of human kidney allograft rejection. Le Mauff B; Hourmant M; Le Meur Y; Dantal J; Cantarovich D; Caudrelier P; Alberici G; Soulillou JP Transplant Proc; 1995 Feb; 27(1):865-6. PubMed ID: 7879210 [No Abstract] [Full Text] [Related]
12. Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection. Davenport A; Younie ME; Parsons JE; Klouda PT Nephrol Dial Transplant; 1994; 9(9):1315-9. PubMed ID: 7816298 [TBL] [Abstract][Full Text] [Related]
13. The use of OKT3 in the treatment of acute vascular rejection. Schroeder TJ; Weiss MA; Smith RD; Stephens GW; Carey M; First MR Transplant Proc; 1991 Feb; 23(1 Pt 2):1043-5. PubMed ID: 1899147 [No Abstract] [Full Text] [Related]
14. The predictive value of arterial renal blood flow parameters in renal graft survival. Łebkowska U; Malyszko J; Łebkowski W; Brzósko S; Kowalewski R; Łebkowski T; Janica J; Michalak P; Gacko M; Myśliwiec M; Walecki J Transplant Proc; 2007 Nov; 39(9):2727-9. PubMed ID: 18021970 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody. Friend PJ; Rebello P; Oliveira D; Manna V; Cobbold SP; Hale G; Jamieson NV; Jamieson I; Calne RY; Harris DT Transplant Proc; 1995 Feb; 27(1):869-70. PubMed ID: 7879212 [No Abstract] [Full Text] [Related]
17. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [TBL] [Abstract][Full Text] [Related]
18. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation. Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183 [No Abstract] [Full Text] [Related]
19. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients. Schroeder TJ; First MR; Mansour ME; Alexander JW; Penn I Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):14-8. PubMed ID: 2510506 [TBL] [Abstract][Full Text] [Related]
20. A comparison of duplex Doppler ultrasonography and intrarenal manometry in the diagnosis of acute renal transplant rejection. Krishnan H; Cochlin D; Moore R; Griffin P; Salaman JR Clin Transplant; 1993 Apr; 7(2):175-8. PubMed ID: 10148532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]